# The Procter & Gamble Manufacturing Company – FDA 483, Nov 17, 2017

Source: https://www.keypedia.com/records/483/the-procter-gamble-manufacturing-company/7135b04c-f517-4517-88cd-2dc0c2af670b

> FDA 483 for The Procter & Gamble Manufacturing Company on November 17, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: The Procter & Gamble Manufacturing Company
- Inspection Date: 2017-11-17
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: The FDA inspected The Procter & Gamble Manufacturing Company in Greensboro, NC, an OTC drug manufacturer. The inspection revealed significant deficiencies across multiple areas, including a lack of process validation for packaging and labeling, inadequate supplier qualification, and poor complaint handling procedures. Additionally, the firm failed to properly maintain and sanitize equipment and utensils, leading to potential contamination risks.

## Related Documents

- [483 - 2023-03-10](https://www.keypedia.com/records/483/the-procter-gamble-manufacturing-company/bd3adbd8-4ae7-4737-9860-be1df7b8fc6b) — date: March 10, 2023
- [EIR - 2023-03-10](https://www.keypedia.com/records/eir/the-procter-gamble-manufacturing-company/48610638-4d54-409d-a30b-edb795ac7c79) — date: March 10, 2023

## Related Officers

- [investigator](https://www.keypedia.com/people/tajah-l-blackburn/27b25d9d-3186-4b3a-a511-2f693d3c889a)
- [Susan O. Oladeji](https://www.keypedia.com/people/susan-o-oladeji/307277f8-7704-4ada-8d8d-d77118c6cb77)

Company: https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/ceebac3f-c234-4225-b666-964153cdba97

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7